Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

Saliva testing for SARS-CoV-2 in children

 
 

Abstract


\n If found to have adequate sensitivity and specificity, saliva would be an ideal sample type for identifying SARS-CoV-2 and other respiratory viruses in children, as its collection is less invasive than other standard upper respiratory tract sample types such as nasopharyngeal swab (NPS), deep nasal/oropharyngeal swab or nasopharyngeal aspirate (NPA). At present, the majority of commercial SARS-CoV-2 assays do not list saliva as an acceptable sample type for nucleic acid testing (NAT) and therefore validation studies assessing the use of this sample type are welcome.\n

Volume None
Pages None
DOI 10.1016/j.cmi.2021.05.046
Language English
Journal Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Full Text